Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn
Research ArticleArticle

Purine Ribonucleoside Kinase Activity and Resistance to Some Analogs of Adenosine

L. LEE BENNETT JR., HANS P. SCHNEBLI, MARGARET H. VAIL, PAULA W. ALLAN and JOHN A. MONTGOMERY
Molecular Pharmacology September 1966, 2 (5) 432-443;
L. LEE BENNETT JR.
Kettering-Meyer Laboratory, Southern Research Institute, Birmingham, Alabama, 35205
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
HANS P. SCHNEBLI
Kettering-Meyer Laboratory, Southern Research Institute, Birmingham, Alabama, 35205
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
MARGARET H. VAIL
Kettering-Meyer Laboratory, Southern Research Institute, Birmingham, Alabama, 35205
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
PAULA W. ALLAN
Kettering-Meyer Laboratory, Southern Research Institute, Birmingham, Alabama, 35205
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
JOHN A. MONTGOMERY
Kettering-Meyer Laboratory, Southern Research Institute, Birmingham, Alabama, 35205
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • eLetters
  • PDF
Loading

Abstract

6-Methylthiopurine ribonucleoside, a cytotoxic nucleoside with antitumor activity, was phosphorylated by cell-free preparations from H.Ep. #2 cells in culture and from yeast. Studies of phosphorylation in the presence of other nucleosides indicated that adenosine kinase was the enzyme catalyzing this phosphorylation and also the phosphorylation of several other cytotoxic nucleosides derived from adenosine by substitution at the 2-position, substitution of other groups for the 6-amino group, or alteration of the ring structure. Cell lines resistant to 6-methylthiopurine ribonucleoside were selected from H.Ep. #2 cells and from a subline resistant to 6-mercaptopurine; a third line resistant to 2-fluoroadenosine was selected from a subline of H.Ep. #2 cells resistant to 2-fluoroadenine. Each of the three resistant cell lines was also resistant to a series of adenosine analogs that were toxic to the parent cell line. The resistant cells were devoid of detectable capacity to phosphorylate 6-methylthiopurine ribonucleoside and adenosine, and this loss persisted when the cells were cultured for many generations in the absence of inhibitor. The resistant cells did not differ from the cell lines from which they were derived in capacity to utilize purines. These results indicate that adenosine kinase is an enzyme essential for the activation of many cytotoxic nucleosides and that loss of this enzyme activity is a mechanism of resistance to these nucleosides.

ACKNOWLEDGMENTS We are grateful to Miss H. J. Thomas for synthesis of 35S-labeled compounds; Miss D. Adamson and Miss S. Hudson for provision of cell cultures; Miss S. Chumley for assays of nucleotide pyrophosphorylases; and Mr. T. C. Herren and Mr. W. Gooden for assays of radioisotopes. This work was supported by Contract No. PH43-66-29, Cancer Chemotherapy National Service Center, National Cancer Institute, National Institutes of Health, and by grants from the C. F. Kettering Foundation and the Alfred P. Sloan Foundation.

  • Copyright ©, 1966, by Academic Press Inc.

MolPharm articles become freely available 12 months after publication, and remain freely available for 5 years. 

Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page. 

 

  • Click here for information on institutional subscriptions.
  • Click here for information on individual ASPET membership.

 

Log in using your username and password

Forgot your user name or password?

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.
PreviousNext
Back to top

In this issue

Molecular Pharmacology
Vol. 2, Issue 5
1 Sep 1966
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Editorial Board (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Molecular Pharmacology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Purine Ribonucleoside Kinase Activity and Resistance to Some Analogs of Adenosine
(Your Name) has forwarded a page to you from Molecular Pharmacology
(Your Name) thought you would be interested in this article in Molecular Pharmacology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

Purine Ribonucleoside Kinase Activity and Resistance to Some Analogs of Adenosine

L. LEE BENNETT, HANS P. SCHNEBLI, MARGARET H. VAIL, PAULA W. ALLAN and JOHN A. MONTGOMERY
Molecular Pharmacology September 1, 1966, 2 (5) 432-443;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleArticle

Purine Ribonucleoside Kinase Activity and Resistance to Some Analogs of Adenosine

L. LEE BENNETT, HANS P. SCHNEBLI, MARGARET H. VAIL, PAULA W. ALLAN and JOHN A. MONTGOMERY
Molecular Pharmacology September 1, 1966, 2 (5) 432-443;
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • eCB Signaling System in hiPSC-Derived Neuronal Cultures
  • Benzbromarone relaxes airway smooth muscle via BK activation
  • Relapsed-leukemia model with NT5C2/PRPS1 hotspot mutations
Show more Articles

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics